Jin Medical International ZJYL Balance Sheet (2022-2026)

NASDAQ ZJYL
$2.06 -0.19 (-8.44%)
At close: Sep 10, 2026 · 4:00 PM EDT
Reported Financials

Jin Medical International Quarterly Balance Sheet

Periods 8 quarters
Latest Mar 2026

Jin Medical International reported total assets of $0.06B and total liabilities of $0.03B for the quarter ended Mar 2026, up 35.7% year over year. This balance sheet covers 8 quarters of results from Sep 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Short-term InvestmentsInvestments (Current) 2,276.16B0.00B9,768.83B17,113.10B18,621.25B19,824.67B0.02B0.02B
Cash & Current Investments 2,276.16B0.01B9,768.84B17,113.11B18,621.26B19,824.69B0.03B0.03B
Receivables - NetNet Receivables 0.00B0.00B0.00B3,856.53B0.01B4,238.72B0.01B0.01B
Receivables - OtherOther Receivables 0.00B0.00B4,240.52B65.04B0.01B137.55B0.01B0.01B
Receivables 0.00B0.01B4,240.53B3,921.57B0.02B4,376.27B0.02B0.02B
Raw Materials 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Work In Process 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Finished Goods 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Inventory 6,724.41B0.01B5,053.14B4,540.85B5,173.46B4,455.06B0.00B0.01B
Prepaid Assets 989.34B0.00B892.60B2,202.85B2,325.03B2,607.50B0.00B0.00B
Current Assets 18,903.15B0.03B31,115.81B38,177.84B42,816.22B43,780.96B0.04B0.04B
Non-Current Assets
Land & Improvements 0.00B0.00B0.00B0.00B
Property, Plant & Equipment (Net)PP&E (Net) 1,627.96B0.00B1,480.80B1,464.11B1,460.29B3,337.80B0.01B0.01B
Long-Term Investments 0.00B0.01B0.01B0.01B0.01B0.01B
Intangibles 0.00B0.00B0.00B
Goodwill & Intangibles 0.00B0.00B0.00B
Long-Term Deferred Tax 245.21B0.00B152.47B130.44B121.32B134.45B0.00B0.00B
Other Non-Current Assets 0.00B0.00B0.00B0.00B0.00B0.00B
Non-Current Assets 0.00B0.00B0.00B0.00B2,984.55B0.00B0.01B0.01B
Assets 0.02B0.03B0.03B0.04B0.05B0.05B0.05B0.06B
Liabilities
Current Liabilities
Accounts Payables 4,113.62B0.00B3,391.08B3,146.45B3,012.33B3,056.06B0.00B0.00B
Notes Payables 0.00B4,113.00B9,681.15B11,322.44B15,726.65B
Payables 4,113.62B0.01B7,504.08B12,827.60B14,334.77B18,782.71B0.00B0.00B
Accumulated Expenses 393.76B0.00B318.50B527.82B431.00B450.45B0.00B0.00B
Other Accumulated Expenses 118.07B0.00B0.00B138.66B280.55B275.74B0.00B0.00B
Short term Debt 0.00B0.01B0.01B0.02B0.02B0.02B
Current Leases 88.30B185.15B159.42B0.00B0.00B
Current Taxes 0.00B0.00B0.00B0.00B1,123.57B0.00B0.00B0.00B
Current Deferred Revenue 830.30B0.00B710.10B546.99B671.41B346.41B0.00B0.00B
Total Current Liabilities 5,703.84B0.01B8,924.34B14,825.52B17,152.13B20,737.08B0.02B0.02B
Non-Current Liabilities
Non-Current Debt 0.00B
Preferred Stock Liabilities 0.00B
Minority Interest -89.25B-262.72B-156.23B-0.00B-0.00B
Operating Leases 179.69B96.17B30.09B
Other Non-Current Liabilities 0.00B0.00B0.00B0.00B
Total Non-Current Liabilities 0.01B179.69B96.17B30.09B0.02B0.00B
Total Liabilities 0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.03B
Shareholder's Equity
Total Debt 0.00B4,113.00B9,681.16B11,322.45B15,726.66B0.02B0.02B
Common Equity 0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B
Liabilities and Shareholders Equity 0.02B0.03B0.03B0.04B0.05B0.05B0.05B0.06B
Retained Earnings 14,408.84B0.02B16,927.60B18,455.16B20,021.35B19,860.87B0.02B0.02B